Avinger Stock Forum

$Avinger (AVGR.US)$
Avinger Releases Updated Data From IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention
Avinger hosted a webinar featuring key opinion leaders discussing new approaches to treating Peripheral Artery Disease (PAD) Below-the-Knee (BTK). The webinar presented updated data from the IMAGE-BTK study, which evaluated the safety and efficacy of Pantheris SVdevice in BTK procedures. The study enrolled 51 patients with 58 lesions, with follow-up ...

$NewGenIvf (NIVF.US)$
$Bright Minds Biosciences (DRUG.US)$ 
next target
$Avinger (AVGR.US)$
$Tivic Health Systems (TIVC.US)$
$Sequans Communications (SQNS.US)$

$Avinger (AVGR.US)$ today’s 80% play

$Avinger (AVGR.US)$ Avinger Announces Issuance of New U.S. Patent and Receives Notices of Allowance for Five Additional U.S. Patents
Accesswire· 4 mins ago

$Avinger (AVGR.US)$  They just dropping it down so everyone will think they about to miss out on selling for a profit and they ll go ahead and sell as it drops and then before close or at premarket this thing will take off!

$Avinger (AVGR.US)$ trash

$Avinger (AVGR.US)$ HTB with FINTEL showing 100K LTB!

$Avinger (AVGR.US)$ 2$

$Avinger (AVGR.US)$ Avinger To Be Issued U.S. Patent Number 12,089,868 Tomorrow Titled "METHODS OF USING ATHERECTOMY CATHETER WITH DEFLECTABLE DISTAL TIP (FOR THE TREATMENT OF OCCLUSIVE CORONARY ARTERY DISEASE)".

$Avinger (AVGR.US)$ Avinger will be issued US patent number 12,089,868 tomorrow titled "METHODS OF USING ATHERECTOMY CATHETER WITH DEFLECTABLE DISTAL TIP (FOR THE TREATMENT OF OCCLUSIVE CORONARY ARTERY DISEASE)".